Cite
HARVARD Citation
Riedel, R. et al. (2020). A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study. Oncologist. pp. e1655-e1662. [Online].